The Göttingen Campus

The Göttingen location has come to be synonymous with high-quality international research. To ensure that this remains the case in the future, the University of Göttingen, including the University Medical Center, and eight non-university local research centres have joined forces to form the Göttingen Campus.

By drawing on their joint strengths and potential, campus partners have created a unique and stimulating environment that encourages diversity and an active exchange between professors, researchers and doctoral students.

Across the Göttingen Campus, there are currently more than 5,900 researchers working in nearly every scientific discipline.

Within the Göttingen Campus, the quality of teaching and training of early career scientists is assured and continuously improved by joint graduate programmes and inter-institute junior research groups.

Science on campus benefits from excellent joint third-party funded projects and 23 joint professorships between the University and non-university institutions.

Latest news

  • Research team led by University of Göttingen reconstructs late medieval trade routes digitally
    The Hanseatic League was a confederation of merchant guilds and market towns in Northwestern and Central Europe, which came to dominate trade in the region for three hundred years. A digital platform has now been built which reveals the long-distance trade routes in Northern Europe between 1350 and 1650. The Research Center for Hanse and Baltic History, the Universities of Magdeburg, Aarhus and Nijmegen, and a team from the University of…
    Read more
  • A new study uncovers how forces with unprecedented controllability can be transmitted in electrolyte solutions across large length scales.
    Solutions that conduct electricity, ‘electrolytes’, are ubiquitous not only in batteries and capacitors but also in biofluids including blood plasma; of great practical importance is thus to understand how electrolytes can be utilised to control living cells or other objects that are immersed in them. In a new study published in Physical Review Letters, researchers from the Max Planck Institute for Dynamics and Self-Organization (MPIDS) in…
    Read more
  • Camostat and nafamostat promising candidates
    While the first vaccines against SARS-CoV-2 have now been approved in Europe and other countries, drugs for specific and efficient treatment of COVID-19 have as yet only limited availability – but are urgently needed. Because of the typical long drug development timelines, the approach of iCAIR® researchers is based on drug repurposing – the use of drugs that have already been approved for other therapeutic purposes. To begin with, researchers…
    Read more
  • Research team led by the University of Göttingen discovers crater floor sagging from bowl-shaped volcanic ash layer
    The almost 15-million-year-old Nördlinger Ries is an asteroid impact crater filled with lake sediments. Its structure is comparable to the craters currently being explored on Mars. In addition to various other deposits on the rim of the basin, the crater fill is mainly formed by stratified clay deposits. Unexpectedly, a research team led by the University of Göttingen has now discovered a volcanic ash layer in the asteroid crater. In addition,…
    Read more
  • A team of researchers, including scientists from the Max Planck Institute (MPI) for Biophysical Chemistry in Göttingen, has identified several candidates for drugs against the SARS-CoV-2 coronavirus using the PETRA III X-ray light source at the German Electron Synchrotron (DESY)
    A team of researchers, including scientists from the Max Planck Institute (MPI) for Biophysical Chemistry in Göttingen, has identified several candidates for drugs against the SARS-CoV-2 coronavirus using the PETRA III X-ray light source at the German Electron Synchrotron (DESY). Among them are two promising compounds that are currently being investigated in preclinical studies. This drug screening – probably the largest of its kind – also…
    Read more